Estimates based on drug properties and standard treatment parameters.
25.9 mL/min
Poorly Dialyzable
Minimal removal expected. Half-life: 5 hours (3.5โ6.5 hours). No supplementation needed.
Data Used:
โ
protein_binding, molar_mass, mw_factor, vd, vd_factor, half_life
Free fraction:
0.48
Mw factor:
1
Vd factor:
0.2
Hl factor:
1
Half life:
5 hours (3.5โ6.5 hours)
Half life category:
Intermediate (4-12h)
2.6 mL/min
Low PD Clearance
Minimal removal expected. No supplementation needed. Half-life: 5 hours (3.5โ6.5 hours).
Data Used:
โ
protein_binding, molar_mass, half_life
Free fraction:
0.48
Half life:
5 hours (3.5โ6.5 hours)
Half life category:
Intermediate (4-12h)
Low Risk
This drug is unlikely to be significantly removed by TPE.
Data Used:
โ
protein_binding, vd, half_life
Half life:
5 hours (3.5โ6.5 hours)
Half life category:
Intermediate (4-12h)
Low Effectiveness
Poor candidate for hemoperfusion. Drug is distributed in tissues.
Data Used:
โ
vd, half_life
Half life:
5 hours (3.5โ6.5 hours)
Half life category:
Intermediate (4-12h)